000 01279 a2200325 4500
005 20250516062316.0
264 0 _c20120517
008 201205s 0 0 eng d
022 _a2152-2669
024 7 _a10.1016/j.clml.2011.02.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCatovsky, Daniel
245 0 0 _aChlorambucil--still not bad: a reappraisal.
_h[electronic resource]
260 _bClinical lymphoma, myeloma & leukemia
_cJun 2011
300 _aS2-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aChlorambucil
_xadministration & dosage
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aDisease-Free Survival
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdrug therapy
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aElse, Monica
700 1 _aRichards, Sue
773 0 _tClinical lymphoma, myeloma & leukemia
_gvol. 11 Suppl 1
_gp. S2-6
856 4 0 _uhttps://doi.org/10.1016/j.clml.2011.02.006
_zAvailable from publisher's website
999 _c21266662
_d21266662